Aveanna Healthcare Holdings Inc has a consensus price target of $4.19 based on the ratings of 13 analysts. The high is $9.5 issued by Credit Suisse on March 30, 2022. The low is $1 issued by Credit Suisse on August 11, 2023. The 3 most-recent analyst ratings were released by Truist Securities, RBC Capital, and Deutsche Bank on January 6, 2025, August 9, 2024, and August 9, 2024, respectively. With an average price target of $5.08 between Truist Securities, RBC Capital, and Deutsche Bank, there's an implied 5.90% upside for Aveanna Healthcare Holdings Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Aveanna Healthcare Hldgs (NASDAQ:AVAH) was reported by Truist Securities on January 6, 2025. The analyst firm set a price target for $5.25 expecting AVAH to rise to within 12 months (a possible 9.38% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Aveanna Healthcare Hldgs (NASDAQ:AVAH) was provided by Truist Securities, and Aveanna Healthcare Hldgs maintained their hold rating.
There is no last upgrade for Aveanna Healthcare Hldgs
The last downgrade for Aveanna Healthcare Holdings Inc happened on December 13, 2023 when JP Morgan changed their price target from N/A to N/A for Aveanna Healthcare Holdings Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aveanna Healthcare Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aveanna Healthcare Hldgs was filed on January 6, 2025 so you should expect the next rating to be made available sometime around January 6, 2026.
While ratings are subjective and will change, the latest Aveanna Healthcare Hldgs (AVAH) rating was a maintained with a price target of $6.00 to $5.25. The current price Aveanna Healthcare Hldgs (AVAH) is trading at is $4.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.